-The Times of India NEW DELHI: Less than two of every 100 senior citizens in India are covered under public and private health insurance. This even as the population of elderly people is growing significantly and is forecast to hit almost 300 million in around two decades. The elderly population, aged more than 60 years, is projected to constitute 18.3% of the total population in 2050, up from 7.7% in 2010, according...
More »SEARCH RESULT
Total Matching Records found : 683
Why axe only MGNREGA? Mr Modi, we need to talk -Abhijit Banerjee
-The Hindustan Times One does not have to agree with his views to be intrigued by the possibilities opened up by Prime Minister Narendra Modi's emergence as communicator/harangue-master in chief. Public conversations about who we are and who we want to be are key to the vitality of our democracy, and leaders can seed those conversations when they speak out their own views. When I hear people in the Delhi metro...
More »Health insurance for all likely in January -Sushmi Dey
-The Times of India NEW DELHI: The government is likely to roll out its much touted National Health Assurance Mission (NAHM) in January, promising health insurance for all. The PMO last week asked the health ministry to work out the modalities of the scheme as well as revamp the existing Rashtriya Swasthya Bima Yojana (RSBY) to expand its span to include universal coverage, said an official. RSBY, currently managed by the labour...
More »Contaminated water leading to cancer, fear Indian villagers -Neeta Lal
-The Third Pole Villagers in India's Greater Noida district could be the latest victims of groundwater contamination with reports of increased cancer cases spurring investigations and concern about the situation elsewhere in the country The perils of groundwater contamination were again in the spotlight recently when media reports about drinking water causing cancer surfaced from five villages in an industrial belt on the outskirts of the Indian capital New Delhi. As medical experts...
More »New hepatitis drug to cost more in middle income nations; activists cry foul -Jyotsna Singh
-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...
More »
